药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Gusperimus
The risk or severity of adverse effects can be increased when Palbociclib is combined with Gusperimus.
Tasosartan
Mizoribine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Mizoribine.
Tasosartan
Triptolide
The risk or severity of adverse effects can be increased when Palbociclib is combined with Triptolide.
Tasosartan
Ocrelizumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Ocrelizumab.
Tasosartan
Guselkumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Guselkumab.
Tasosartan
Sirukumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Sirukumab.
Tasosartan
Brodalumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Brodalumab.
Tasosartan
Peficitinib
The risk or severity of adverse effects can be increased when Palbociclib is combined with Peficitinib.
Tasosartan
Voclosporin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Voclosporin.
Tasosartan
Pirarubicin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Pirarubicin.
Tasosartan
Ravulizumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Ravulizumab.
Tasosartan
Ixekizumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Ixekizumab.
Tasosartan
Melengestrol
The risk or severity of adverse effects can be increased when Palbociclib is combined with Melengestrol.
Tasosartan
Tepoxalin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Tepoxalin.
Tasosartan
Fluprednisolone
The risk or severity of adverse effects can be increased when Palbociclib is combined with Fluprednisolone.
Tasosartan
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Palbociclib is combined with Antilymphocyte immunoglobulin (horse).
Tasosartan
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Palbociclib is combined with Peginterferon beta-1a.
Tasosartan
Tixocortol
The risk or severity of adverse effects can be increased when Palbociclib is combined with Tixocortol.
Tasosartan
Vilanterol
The risk or severity of adverse effects can be increased when Palbociclib is combined with Vilanterol.
Tasosartan
Dinutuximab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Dinutuximab.